تكلس الكلى
مراجعة من قبل الدكتورة هايلي ويلاسي، زميلة الكلية الملكية للأطباء العامين آخر تحديث بواسطة الدكتور كولين تايدي، MRCGPآخر تحديث 10 مايو 2023
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
المهنيين الطبيين
تم تصميم مقالات المراجع المهنية لاستخدامها من قبل المتخصصين في الرعاية الصحية. يتم كتابتها بواسطة أطباء من المملكة المتحدة وتستند إلى الأدلة البحثية والإرشادات البريطانية والأوروبية. قد تجد أحد مقالاتنا مقالاتنا الصحية أكثر فائدة.
What is nephrocalcinosis?1 2 3
Nephrocalcinosis is defined as generalised deposition of calcium phosphate and/or calcium oxalate in the kidney, predominantly in the interstitium. Calcifications in renal pyramids, characteristic of medullary nephrocalcinosis, are seen in 98% of nephrocalcinosis patients.
Clinical presentation and course are not dependent on the severity of nephrocalcinosis. The critical feature in nephrocalcinosis is hypercalciuria with or without hypercalcaemia.
Nephrocalcinosis is closely associated with renal stone formation (urolithiasis) resulting from increased urinary calcium levels (hypercalciuria).4
Advances in uroendoscopy have led to a further definition: the radiographic demonstration of diffuse, fine renal parenchymal calcifications.5
Nephrocalcinosis can be divided into three categories (there is invariably a degree of overlap between the categories):
Chemical nephrocalcinosis: increased concentration of calcium in renal cells, especially the tubular epithelium, causing adverse effects on renal structure and function - eg, increased excretion of water, sodium, potassium, calcium and magnesium.
Microscopic nephrocalcinosis: calcium precipitates in crystalline form as oxalate and/or phosphate; however, it is only seen with the aid of a microscope.
Macroscopic nephrocalcinosis: large areas of calcification can be seen.
Nephrocalcinosis may be associated with renal calculi but is more likely to represent an underlying metabolic disorder. It can also be differentiated into:
Medullary nephrocalcinosis:
The most frequent form, characterised by the exclusive involvement of the medullary pyramids.
It is usually associated with disordered calcium homeostasis.
Cortical nephrocalcinosis:
Rarer and involving all the renal parenchyma.
Frequently associated with severe metabolic defects, such as primary hyperoxaluria or end-stage kidney disease.
The most frequent causes are chronic glomerulonephritis and acute cortical necrosis.
Other causes include haemolytic uraemic syndrome, chronic pyelonephritis, vesicoureteral reflux, renal transplantation and polycystic kidney disease.
Nephrocalcinosis epidemiology
Microscopic nephrocalcinosis is a common incidental finding at post-mortem but macroscopic nephrocalcinosis is uncommon.
What causes nephrocalcinosis? (Aetiology)2
Medullary nephrocalcinosis
فرط كالسيوم الدم: for example, diet, فرط نشاط الغدة الجار درقية, vitamin D excess, bone metastases, bone loss from chronic immobilisation and severe osteoporosis, sarcoidosis, idiopathic hypercalcaemia of infancy (Williams' disease).
Hypercalciuria:
Altered renal tubular handling - eg, idiopathic hypercalciuria, distal renal tubular acidosis (is associated with low urinary excretion of citrate), hypothyroidism, inherited tubular disorders (eg, Bartter's syndrome and familial magnesium-losing nephropathy), and may follow intensive loop diuretic treatment in premature infants.
Hypercalciuria is also a feature of متلازمة فانكوني و proximal renal tubular acidosis; however, these conditions are less commonly associated with nephrocalcinosis.
Absence of factors in urine (eg, citrate) that help to maintain calcium salts in solution - eg, in conditions causing chronic hypokalaemia (مثل،, primary hyperaldosteronism).
Cortical nephrocalcinosis
Acute renal cortical necrosis: causes include infection, extracorporeal shock wave lithotripsy, haemolytic uraemic syndrome.
Primary and secondary oxalosis.
Intrarenal infections in HIV-seropositive patients.
Renal graft rejection.
Nephrocalcinosis symptoms (presentation)2
The underlying aetiology primarily determines the presentation of nephrocalcinosis, although in most cases it is asymptomatic and is identified as an abnormality on imaging of the renal tract.
Presentation can range from incidental detection on abdominal X-rays or ultrasounds performed for another reason, to life-threatening.
Hypercalcaemia: polyuria and polydipsia, nausea and vomiting.
May cause hypertension.
In medullary nephrocalcinosis, calcium nodules commonly rupture into the calyceal system to form urinary stones and cause renal colic, haematuria, urinary tract infections or the passage of urinary stones.
May rarely present with features of acute kidney injury or chronic kidney disease.
Presenting symptoms in children include failure to thrive in the first year of life, urinary tract infections, bladder voiding dysfunction or abdominal pain, and psychomotor delay.7
التحقيقات2
اختبارات الدم
Serum calcium, phosphate, albumin: to establish the presence of hypercalcaemia.
Serum electrolytes and assessment of renal function.
Parathyroid hormone levels.
Thyroid-stimulating hormone (TSH) levels.
Urine investigations
Urinalysis with microscopy and culture: evidence of urinary tract infection.
24-hour urinary excretion of calcium, oxalate, citrate and protein: assessment of hypercalciuria and possible nephrotic syndrome.
Urinary magnesium: magnesium-losing nephropathy.
Radiology
Abdominal X-rays: detection of nephrocalcinosis, urinary stones.
Ultrasound: more sensitive than conventional radiography and can be superior to CT scan in some clinical scenarios (eg, nephrocalcinosis associated with hypoparathyroidism).8
CT scan: more effective in detecting calcification and can be used to differentiate medullary and cortical deposition.
تنظير داخلي
When calcification in close association with the renal papillae is seen on CT scans, distinguishing nephrolithiasis from nephrocalcinosis may require direct visual inspection using endoscopy.5
خزعة الكلى
May be required in the assessment of the underlying cause.
الفحص الجيني
May play an increasing role in nephrocalcinosis presenting in children in the future.9
الأمراض المرتبطة
Nephrocalcinosis and urinary calculi may co-exist. Nephrocalcinosis and calcium nephrolithiasis are considered as two independent pathologies.10
Common associated conditions include:
Furosemide therapy (neonatal).
Rarer associated conditions include:
Phosphate and vitamin D in X-linked hypophosphataemic rickets.
Hyperphosphatasia.
السل.
Vitamin D intoxication.
Prolonged immobilisation.
Idiopathic hypercalciuria.
Oculocerebral syndrome.
Acetazolamide.
Cerebrotendinous xanthomatosis.
Dent's disease.
Nephrocalcinosis treatment and management11
انظر أيضًا إلى منفصل فرط كالسيوم الدم مقالة.
Ensure adequate fluid intake.
Treatment of the underlying condition - eg, parathyroidectomy to control a hyperfunctioning parathyroid gland.
Early treatment of reversible causes of renal failure, such as treatment of urinary infections, calculous obstruction and hypertension, is essential.
Once renal failure is established, it must be treated accordingly. See separate إصابة الكلى الحادة و مرض الكلى المزمن مقالات.
Surgical intervention may be required for significant stone formation in the renal tract, especially if causing obstruction or infection.
Lithotripsy may cause renal damage, as the calcium deposition is largely parenchymal.
المضاعفات11
May lead to uncontrolled hypertension, renal infection, scarring, renal colic, defects of renal tubular function and مرض الكلى المزمن.
التكهن
The prognosis depends mainly on the aetiology of the nephrocalcinosis.
Early diagnosis and treatment of the underlying condition in children is associated with catch-up growth and stabilisation of glomerular function in many children but not with the reduction in the degree of nephrocalcinosis in the majority of cases.7
تحديثات حصرية لمتخصصي الرعاية الصحية
ابقَ على اطلاع بأحدث التحديثات السريرية، والرؤى المهنية، والإرشادات المستندة إلى الأدلة. تقوم نشرة Patient Pro الإخبارية بتجميع محتوى أساسي لمتخصصي الرعاية الصحية - يتم تسليمه مباشرة إلى بريدك الوارد.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.
قراءة إضافية ومراجع
- Vaidya SR, Yarrarapu SNS, Aeddula NR; Nephrocalcinosis. StatPearls, August 2022.
- Shavit L, Jaeger P, Unwin RJ; What is nephrocalcinosis? Kidney Int. 2015 Jul;88(1):35-43. doi: 10.1038/ki.2015.76. Epub 2015 Mar 25.
- Oliveira B, Kleta R, Bockenhauer D, et al; Genetic, pathophysiological, and clinical aspects of nephrocalcinosis. Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1243-F1252. doi: 10.1152/ajprenal.00211.2016. Epub 2016 Sep 7.
- Kumbar L, Yee J; Nephrocalcinosis: A Diagnostic Conundrum. Am J Kidney Dis. 2018 Apr;71(4):A12-A14. doi: 10.1053/j.ajkd.2017.11.025.
- Dickson FJ, Sayer JA; Nephrocalcinosis: A Review of Monogenic Causes and Insights They Provide into This Heterogeneous Condition. Int J Mol Sci. 2020 Jan 6;21(1):369. doi: 10.3390/ijms21010369.
- Miller NL, Humphreys MR, Coe FL, et al; Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec;38(6):421-7. Epub 2010 Nov 6.
- Schepens D, Verswijvel G, Kuypers D, et al; Images in Nephrology. Renal cortical nephrocalcinosis. Nephrol Dial Transplant. 2000 Jul;15(7):1080-2.
- Ammenti A, Pelizzoni A, Cecconi M, et al; Nephrocalcinosis in children: a retrospective multi-centre study. Acta Paediatr. 2009 Oct;98(10):1628-31. Epub 2009 Jul 1.
- Boyce AM, Shawker TH, Hill SC, et al; Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab. 2013 Mar;98(3):989-94. doi: 10.1210/jc.2012-2747. Epub 2013 Jan 24.
- Halbritter J, Baum M, Hynes AM, et al; Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015 Mar;26(3):543-51. doi: 10.1681/ASN.2014040388. Epub 2014 Oct 8.
- Vervaet BA, Verhulst A, D'Haese PC, et al; Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant. 2009 Jul;24(7):2030-5. Epub 2009 Mar 18.
- Gambaro G, Trinchieri A; Recent advances in managing and understanding nephrolithiasis/nephrocalcinosis. F1000Res. 2016 Apr 18;5:F1000 Faculty Rev-695. doi: 10.12688/f1000research.7126.1. eCollection 2016.
حول المراجععرض السيرة الذاتية الكاملة

الدكتورة هايلي ويلاسي، زميلة الكلية الملكية للأطباء العامين
طبيب عام، مؤلف طبي
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
كانت الدكتورة هايلي ويلاسي طبيبة عامة في هيئة الخدمات الصحية الوطنية تعمل في شمال غرب إنجلترا، وتقاعدت من الممارسة السريرية في عام 2022 بعد 30 عامًا.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
المراجعة التالية مستحقة: 8 مايو 2028
10 مايو 2023 | أحدث إصدار
آخر تحديث بواسطة
الدكتور كولين تايدي، MRCGPمراجعة من قبل
الدكتورة هايلي ويلاسي، زميلة الكلية الملكية للأطباء العامين
المزيد في اضطرابات الكلى (الكلية)
- إصابة الكلى الحادة
- فقر الدم في مرض الكلى المزمن
- احتباس البول المزمن
- داء السكري الكاذب
- اعتلال الكلى السكري
- فرط بوتاسيوم الدم عند الأطفال
- القلاء نقص البوتاسيوم
- اعتلال الكلية بالجلوبيولين المناعي A (IgA)
- أمراض الكلى الوراثية
- ألم الخاصرة
- متلازمة لو (العين-الدماغ-الكلى)
- كلية إسفنجية نخاعية
- الحماض الأيضي
- التبرع بالأعضاء
- خزعة الكلى
- سرطان الكلى
- متلازمة فانكوني الكلوية
- العلاج البديل للكلى وزرع الأعضاء
- تحصي المسالك البولية
- ورم ويلمز


